Cladribine formulations for improved oral and transmucosal delivery

Details for Australian Patent Application No. 2004226435 (hide)

Owner Ares Trading S.A.

Inventors Bodor, Nicholas S.

Agent Griffith Hack

Pub. Number AU-B-2004226435

PCT Pub. Number WO2004/087100

Priority 60/458,922 28.03.03 US; 60/484,756 02.07.03 US; 60/541,246 04.02.04 US

Filing date 26 March 2004

Wipo publication date 14 October 2004

Acceptance publication date 12 November 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/52 (2006.01)

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

20 October 2005 PCT application entered the National Phase

  PCT publication WO2004/087100 Priority application(s): WO2004/087100

29 March 2007 Assignment before Grant

  Ivax Corporation The application has been assigned to Ares Trading S.A.

12 November 2009 Application Accepted

  Published as AU-B-2004226435

18 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226437-Oral formulations of cladribine

2004226434-Longitudinally expanding medical device